Hedging Designation [Domain] Hedging Designation [Domain] Customer [Domain] Customer [Domain] Goodwill Disposal Group, Including Discontinued Operation, Goodwill Convertible Debt Convertible Debt Convertible Debt [Member] Leasehold improvements Leasehold Improvements [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net income Net income Net income Net Income (Loss) Attributable to Parent Operating lease assets Operating Lease, Right-of-Use Asset Income Statement Location [Axis] Income Statement Location [Axis] Interest rate contracts Interest Rate Contract [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-term Debt [Table Text Block] Derivative liabilities Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet Derivative Liability Schedule of Offsetting Assets Offsetting Assets [Table Text Block] Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Summary of a Reconciliation in Contract Liabilities from Contracts with Customer Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Additional paid-in capital Additional paid-in capital Additional Paid in Capital, Common Stock Net income per ordinary share: Earnings Per Share Reconciliation [Abstract] Xyrem Xyrem [Member] Xyrem [Member] Derivative Financial Instruments Derivative, Collateral, Right to Reclaim Securities Other non-current assets Other Assets, Noncurrent Entity Address, Country Entity Address, Country Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Liability, Fair Value, Amount Offset Against Collateral [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Expected dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Acquired in-process research and development assets In Process Research and Development [Member] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Weighted-average volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 2024 Long-Term Debt, Maturity, Year Two Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Income taxes payable Increase (Decrease) in Income Taxes Payable Assets Held for Sale Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] 2022 (remainder) Long-Term Debt, Maturity, Remainder of Fiscal Year FDA stay of approval period FDA Stay Of Approval Period FDA Stay Of Approval Period Subsequent Event Type [Domain] Subsequent Event Type [Domain] Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Intangible asset amortization Intangible asset amortization Amortization of Intangible Assets Contractual coupon rate interest expense Interest Expense, Debt, Contractual Coupon Rate Interest Expense, Debt, Contractual Coupon Rate Remaining Weighted- Average Useful Life (In years) Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Other current assets Other Current Assets [Member] Dilutive effect of Exchangeable Senior Notes (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Cash Collateral Received (Pledged) Derivative, Collateral, Obligation to Return Cash Ordinary shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Components of Inventories Schedule of Inventory, Current [Table Text Block] Contract revenue recognized Amount recognized within royalties and contract revenues Contract with Customer, Liability, Revenue Recognized Research and development Research and Development Expense [Member] Significant Risks and Uncertainties Significant Risks And Uncertainties [Policy Text Block] Describes risks and uncertainties related to the pharmaceutical industry. Subsequent Events [Abstract] Subsequent Events [Abstract] Teamsters and GEHA Lawsuits Teamsters And GEHA Lawsuits [Member] Teamsters And GEHA Lawsuits [Member] Grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Business Acquisition [Axis] Business Acquisition [Axis] Cash Flow Hedges Cash Flow Hedging [Member] Property, plant and equipment, gross and finance lease right out use asset before accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] ASSETS Assets [Abstract] 2025 Long-Term Debt, Maturity, Year Three Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] RSUs granted (in shares) PRSUs granted (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Epidiolex/Epidyolex Epidiolex/Epidyolex [Member] Epidiolex/Epidyolex Research and development Research and Development Expense (Excluding Acquired in Process Cost) Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Percentage of gross accounts receivable (as a percent) Percentage of total revenues (as a percent) Concentration Risk, Percentage Proceeds from employee equity incentive and purchase plans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Debt instrument, convertible, threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Retained Earnings Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Available-for-sale securities: Debt Securities, Available-for-sale [Abstract] Percentage of ownership (as a percent) Noncontrolling Interest, Ownership Percentage by Parent Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Inventory, step-up value Inventory, Step-Up Value Inventory, Step-Up Value 2026 Notes Exchangeable Senior Notes Due 2026 [Member] Exchangeable Senior Notes Due 2026 [Member] Inventory, Current [Table] Inventory, Current [Table] Accounts receivable Increase (Decrease) in Accounts Receivable Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Number of operating business segments Number of Operating Segments Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Basic (in dollars per share) Earnings Per Share, Basic Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Schedule of ASU 2020-06 Adoption Impact on Condensed Balance Sheet Condensed Balance Sheet [Table Text Block] Revenues Revenue from Contract with Customer [Text Block] Jazz Investments I Limited Jazz Investments I Limited [Member] Jazz Investments I Limited [Member] 2023 Long-Term Debt, Maturity, Year One Unamortized - debt issuance costs Unamortized Debt Issuance Expense Interest expense, debt Interest Expense, Debt Prepaid expenses Prepaid Expense, Current Summary of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Total Neuroscience Neuroscience [Member] Neuroscience Erwinaze/Erwinase Erwinaze And Erwinase [Member] Erwinaze And Erwinase [Member] Nippon Shinyaku Nippon Shinyaku Co., Ltd. [Member] Nippon Shinyaku Co., Ltd. [Member] Three Customers Three Customers [Member] Three Customers Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Manufacturing equipment and machinery Machinery and Equipment [Member] Shares withheld for payment of employee's withholding tax liability Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Other non-cash transactions Other Noncash Income (Expense) Gross Amounts of Recognized Assets/ Liabilities Derivative Asset, Fair Value, Gross Asset Number of days for ex-U.S transaction to close after U.S. transaction closes Disposal Group, Including Discontinued Operation, Number Of Days For Ex-U.S. Transaction To Close After U.S. Transaction Closes Disposal Group, Including Discontinued Operation, Number Of Days For Ex-U.S. Transaction To Close After U.S. Transaction Closes Cost of product sales (excluding amortization of acquired developed technologies) Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment Total costs related to goods produced and sold during the reporting period excluding amortization of acquired developed technologies and intangible asset impairment presented separately. Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Offsetting Assets [Line Items] Offsetting Assets [Line Items] Long term debt outstanding Total Long-term Debt, Gross Goodwill [Roll Forward] Goodwill [Roll Forward] Clinical trial accruals Accrued Clinical Trial Liability Accrued Clinical Trial Liability Assets: Assets, Fair Value Disclosure [Abstract] Total debt Long-term Debt Totals Assets, Fair Value Disclosure Loss on fair value hedging activities reclassified from accumulated other comprehensive income (loss) to foreign exchange gain (loss), net of income tax benefit of $43 and $—, respectively Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax, Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax, Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] FDA recognition of orphan drug exclusivity, period FDA Recognition Of Orphan Drug Exclusivity, Period FDA Recognition Of Orphan Drug Exclusivity, Period Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Smaller Reporting Company Entity Small Business Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total liabilities and shareholders’ equity Liabilities and Equity Other Other Accrued Liabilities, Current Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Loss on cash flow hedging activities reclassified from accumulated other comprehensive income (loss) to interest expense, net of income tax benefit of $— and $166, respectively Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Deferred revenue Contract with Customer, Liability, Current Scenario [Axis] Scenario [Axis] Offsetting Liabilities [Table] Offsetting Liabilities [Table] 2029 Senior Notes Senior Notes Due 2029 [Member] Senior Notes Due 2029 Concentration Risk [Line Items] Concentration Risk [Line Items] LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Hedging Relationship [Domain] Hedging Relationship [Domain] Derivative [Line Items] Derivative [Line Items] Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets Offsetting Assets [Table] Offsetting Assets [Table] Net Income per Ordinary Share Earnings Per Share [Text Block] Derivative instrument liabilities Derivative Liability, Current Assets held for sale Total assets held for sale Disposal Group, Including Discontinued Operation, Assets Operating expenses: Operating Expenses [Abstract] Schedule of Income (Losses) on Derivative Instruments Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Xywav Xywav [Member] Xywav Sumitomo Sumitomo [Member] Sumitomo Total Oxybate Total Oxybate [Member] Total Oxybate 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Issuance of ordinary shares in conjunction with exercise of share options Stock Issued During Period, Value, Stock Options Exercised Minimum Minimum [Member] Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Debt instrument, convertible, number of shares per principal amount basis (in shares) Debt Instrument, Convertible, Conversion Ratio Balance Sheet Location [Domain] Balance Sheet Location [Domain] Income before income tax expense and equity in loss (gain) of investees Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Selling, general and administrative Selling, General and Administrative Expense Debt issuance costs Debt Issuance Costs, Net Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Milestone Payment Milestone Payment [Member] Milestone Payment Farrell Lawsuit And Levy Lawsuit Farrell Lawsuit And Levy Lawsuit [Member] Farrell Lawsuit And Levy Lawsuit Selling and marketing accruals Accrued Marketing Costs, Current Amounts reclassified from accumulated other comprehensive income (loss) Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Employee compensation and benefits Accrued Employee Benefits, Current Deferred tax assets, net Deferred tax assets, net Deferred Income Tax Assets, Net Current liabilities: Liabilities, Current [Abstract] 2026 Long-Term Debt, Maturity, Year Four Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Line of Credit Line of Credit [Member] Share-Based Compensation Share-based Payment Arrangement [Text Block] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Inventories Inventory Disclosure [Text Block] Performance-Based Restricted Stock Units (PRSUs) Performance-Based Restricted Stock Units (RSUs) [Member] Performance-Based Restricted Stock Units (RSUs) Acquired IPR&D Acquired IPR&D [Member] Acquired IPR&D Less accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Accounting Policies [Abstract] Accounting Policies [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Consulting and professional services Accrued Professional Fees, Current Cash and Available-for-Sale Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Document Transition Report Document Transition Report Foreign exchange gain (loss) Foreign Currency Transaction Gain (Loss), before Tax Ordinary shares Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Weighted-average period expected to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Customer concentration risk Customer Concentration Risk [Member] 2021 Credit Agreement, Euro Term Loan Two Thousand Twenty One Credit Agreement, Euro Term Loan [Member] Two Thousand Twenty One Credit Agreement, Euro Term Loan Unrealized loss on cash flow hedging activities, net of income tax benefit of $— and ($3), respectively Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax Commitments and contingencies Commitments and Contingencies Subsequent Event [Table] Subsequent Event [Table] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Emerging Growth Company Entity Emerging Growth Company All other Other Countries [Member] Other Countries [Member] Schedule of Weighted-Average Assumptions Used in Black-Scholes Option Pricing Model which was Used to Estimate Grant Date Fair Value per Share Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Tax benefit effect on cash flow hedging activities Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Ownership [Axis] Ownership [Axis] Legal Entity [Axis] Legal Entity [Axis] Cover [Abstract] Cover [Abstract] Dilutive effect of employee equity incentive and purchase plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Non-voting euro deferred shares Nonvoting Euro Deferred Shares Shares issued to satisfy statutory minimum of Euro-denominated share capital required for a public limited company incorporated in Ireland. Total operating expenses Costs and Expenses Cumulative Effect, Period of Adoption, Adjusted Balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Work in process Inventory, Work in Process, Net of Reserves Zepzelca Zepzelca [Member] Zepzelca 2021 Credit Agreement, Revolving Credit Facility Two Thousand Twenty One Credit Agreement, Revolving Credit Facility [Member] Two Thousand Twenty One Credit Agreement, Revolving Credit Facility Financial Instrument [Axis] Financial Instrument [Axis] Selling, general and administrative Selling, General and Administrative Expenses [Member] Entity [Domain] Entity [Domain] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Summary Of Deferred Revenue [Table] Summary Of Deferred Revenue [Table] Summary Of Deferred Revenue [Table] Finished goods Inventory, Finished Goods, Net of Reserves Asset derivatives Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement Employee Stock Option Share-based Payment Arrangement, Option [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Document Quarterly Report Document Quarterly Report Total Oncology Oncology [Member] Oncology Interest income from available-for-sale securities Investment Income, Interest Ordinary Shares Common Stock [Member] Inventories Disposal Group, Including Discontinued Operation, Inventory Other comprehensive loss before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Income from operations Operating Income (Loss) Cardinal Cardinal Health Inc. [Member] Cardinal Health Inc. Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax The Company and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Hedging Designation [Axis] Hedging Designation [Axis] Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Share-based compensation Share-based Payment Arrangement, Noncash Expense Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents Cash and Cash Equivalents, at Carrying Value Fair value of lines of credit Lines of Credit, Fair Value Disclosure Depreciation Depreciation Outside United States Outside United States [Member] Outside United States ESSDS Express Scripts [Member] Express Scripts 1 [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Secured Debt Senior Secured Debt [Member] Senior Secured Debt Accrued liabilities Increase (Decrease) in Accrued Liabilities Notional amount Derivative, Notional Amount Upfront payment Research and Development Asset Acquired Other than Through Business Combination, Written-off Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Net liability fair value Derivative, Fair Value, Net Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Current portion of lease liabilities Lease, Liability, Current Lease, Liability, Current Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Payment for debt extinguishment or debt prepayment cost Payment for Debt Extinguishment or Debt Prepayment Cost Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Defitelio/defibrotide Defitelio/Defibrotide [Member] Defitelio/Defibrotide [Member] Employee equity incentive and purchase plans Equity Unit Purchase Agreements [Member] Summary of Revenues from Customers Representing More Than 10% of Total Revenues Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Total shareholders’ equity Beginning balance Cumulative effect adjustment from adoption of ASU 2020-06 Ending balance Stockholders' Equity Attributable to Parent City Area Code City Area Code Other Other Products [Member] Other Products [Member] Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Operating lease assets Increase (Decrease) In Operating Lease Assets Increase (Decrease) In Operating Lease Assets Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Entity Address, City or Town Entity Address, City or Town Shareholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Components of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Rebates and other sales deductions Accrued Rebates And Other Sales Deductions Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and other sales deductions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Loss on disposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Computer software Software and Software Development Costs [Member] Number of markets product approved and marketed Number Of Markets Product Approved And Marketed Number Of Markets Product Approved And Marketed Concentrations of Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Financing and Payment [Line Items] Summary Of Deferred Revenue [Line Items] [Line Items] for Summary Of Deferred Revenue [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Range of risk-free rates, minimum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Operating lease liabilities, less current portion Operating Lease, Liability, Noncurrent Accrued liabilities Accrued Liabilities [Member] Accounting Standards Update [Axis] Accounting Standards Update [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Debt instrument, face amount Debt Instrument, Face Amount Interest expense Interest Expense Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Discontinued Operations and Disposal Groups [Abstract] Income tax benefit from share-based compensation expense Share-based Payment Arrangement, Expense, Tax Benefit Derivative assets Derivative Asset [Abstract] Non-voting Euro Deferred Euro Deferred Shares [Member] Euro Deferred Shares [Member] Retained earnings Retained earnings Retained Earnings (Accumulated Deficit) Litigation Case [Domain] Litigation Case [Domain] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Achievement target, percentage of awards granted Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted Cross-currency interest rate contracts Cross Currency Interest Rate Contract [Member] Schedule of Foreign Exchange Gain (Loss) of Outstanding Derivatives Derivative Instruments, Gain (Loss) [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Concentration Risk [Table] Concentration Risk [Table] Schedule of Income (Losses) on Derivative Instruments Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss) Entity Registrant Name Entity Registrant Name Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Fair value of secured debt Notes Payable, Fair Value Disclosure Acquired in-process research and development assets Indefinite-lived Intangible Assets (Excluding Goodwill) Offsetting Liabilities [Line Items] Offsetting Liabilities [Line Items] Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Asset, Fair Value, Amount Offset Against Collateral [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Income tax expense Income Tax Expense (Benefit) Accounts receivable, net of allowances Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Equity Components [Axis] Equity Components [Axis] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Schedule of Cash and Cash Equivalents and Investments Cash, Cash Equivalents and Investments [Table Text Block] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Provision for losses on accounts receivable and inventory Provision For Losses On Accounts Receivable And Inventory Amount of the current period expense charged against operations (1) for the purpose of reducing receivables to an amount that approximates their net realizable value and (2) the charge to cost of goods sold that represents the reduction off the carrying amount of inventory, generally attributable to obsolescence or market conditions. Acquisition accounting inventory fair value step-up adjustment Inventory Step-Up Value Adjustment The noncash expense recognized in the current period from the amortization of acquired inventory written up to fair value in purchase accounting Document Fiscal period Focus Document Fiscal Period Focus Sativex Sativex [Member] Sativex Total current assets Assets, Current Gross accounts receivable Accounts Receivable [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories Total inventories Inventory, Net Loss reclassified from accumulated other comprehensive income (loss) to interest expense, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Sunosi Sunosi [Member] Sunosi [Member] Accrued milestones Accrued Milestones Accrued Milestones Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Payment terms, range Revenue, Performance Obligation, Payment Terms Revenue, Performance Obligation, Payment Terms Inventory-related accruals Accrued Inventory Related Liabilities Accrued Inventory Related Liabilities Current portion of long-term debt Less current portion Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Equity securities without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Amount Weighted-average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Gross Carrying Amounts and Net Book Values of Intangible Assets Schedule Of Finite Lived And Indefinite Lived Intangible Assets [Table Text Block] Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance, both finite life and indefinite life, by major class. Statement [Line Items] Statement [Line Items] Litigation Case [Axis] Litigation Case [Axis] Loss recognized in accumulated other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Property, plant and equipment, net Property, plant, and equipment and finance lease right-of-use asset, after accumulated depreciation and amortization, total Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Acquisition of investments Payments to Acquire Investments Deferred financing costs Debt Issuance Costs, Noncurrent, Net Sales return reserve Sales Return Reserve Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales returns reserve. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Revenue, performance obligation, description of timing Revenue, Performance Obligation, Description of Timing Estimated Fair Value Available-for-sale securities Debt Securities, Available-for-sale Proceeds from maturity of investments Proceeds from Sale, Maturity and Collection of Investments Counterparty Name [Domain] Counterparty Name [Domain] Fair value of exchangeable senior notes Convertible Debt, Fair Value Disclosures Intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Debt Disclosure [Abstract] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Accounting Standards Update [Domain] Accounting Standards Update [Domain] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Deferred revenue, non-current Contract with Customer, Liability, Noncurrent Loss recognized in foreign exchange gain (loss) Derivative, Gain (Loss) on Derivative, Net Tax benefit effect on fair value hedging activities Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Reclassification Adjustment, Tax Upfront payment to be received Disposal Group, Including Discontinued Operation, Upfront Payment To Be Received Disposal Group, Including Discontinued Operation, Upfront Payment To Be Received Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Customer [Axis] Customer [Axis] Land and buildings Land and Building [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Shares underlying options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Schedule of Basic and Diluted Net Income per Ordinary Share Computation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt instrument, convertible, threshold trading days Debt Instrument, Convertible, Threshold Trading Days Other comprehensive loss Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Forecast Forecast [Member] Schedule of Share-Based Compensation Expense Related to Share Options, RSUs , PRSU's and Grants Under ESPP Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Goodwill allocated to assets held for sale Goodwill, Written off Related to Sale of Business Unit Product sales, net Product sales, net Product And Services, Product Sales Net Of Deductions [Member] Product And Services, Product Sales Net Of Deductions [Member] Net Amount Derivative Asset, Fair Value, Amount Offset Against Collateral Title of 12(b) Security Title of 12(b) Security Total assets Assets Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items] Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Line Items] Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items] Geographical [Domain] Geographical [Domain] Repayments of long-term debt Repayments of Secured Debt Document Type Document Type Product and Service [Domain] Product and Service [Domain] Certain Balance Sheet Items Supplemental Balance Sheet Disclosures [Text Block] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Derivative Contract [Domain] Derivative Contract [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Revolving Credit Facility Revolving Credit Facility [Member] Cash Cash [Member] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Furniture and fixtures Furniture and Fixtures [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Other Other Assets, Miscellaneous, Current Subsequent Event [Line Items] Subsequent Event [Line Items] Other Disposal Group, Including Discontinued Operation, Other Assets Geographical [Axis] Geographical [Axis] Numerator: Numerator [Abstract] Numerator [Abstract] Lupin Lawsuit Lupin Lawsuit [Member] Lupin Lawsuit Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Infringed patents suit, number of patents Infringed Patents Suit, Number Of Patents Infringed Patents Suit, Number Of Patents Weighted-average ordinary shares used in per share calculations - basic (in shares) Weighted-average ordinary shares used in per share calculation - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in dollars per share) Diluted (in dollars per share) Earnings Per Share, Diluted Debt instrument, convertible, threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Totals Financial Liabilities Fair Value Disclosure Tax benefit effect on fair value hedging activities Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax Hedging Relationship [Axis] Hedging Relationship [Axis] Accounting Standards Update [Extensible Enumeration] Accounting Standards Update [Extensible Enumeration] Certain Balance Sheet Items [Abstract] Certain Balance Sheet Items [Abstract] Certain Balance Sheet Items [Abstract] Cash Collateral Received (Pledged) Derivative, Collateral, Right to Reclaim Cash Subsequent Events Subsequent Events [Text Block] Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Beginning balance Ending balance Contract with Customer, Liability Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Equity in loss (gain) of investees Income (Loss) from Equity Method Investments Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Schedule of RSU and PRSU Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Fair Value Measurement Fair Value Disclosures [Text Block] Accounts payable Accounts Payable, Current Concentration Risk Type [Axis] Concentration Risk Type [Axis] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Total share-based compensation expense, net of tax Share-based Payment Arrangement, Expense, after Tax 2024 Notes Exchangeable Senior Notes Due 2024 [Member] Exchangeable Senior Notes Due 2024 [Member] 2021 Credit Agreement, Dollar Term Loan Two Thousand Twenty One Credit Agreement, Dollar Term Loan [Member] Two Thousand Twenty One Credit Agreement, Dollar Term Loan Accumulated Other Comprehensive Loss Total Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] 2022 (remainder) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Inventories Increase (Decrease) in Inventories Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table] Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Table] Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table] Accrued royalties Accrued Royalties, Current Capital Redemption Reserve Capital Redemption Reserve [Member] Capital Redemption Reserve [Member] Financial Instruments [Domain] Financial Instruments [Domain] Derivative [Table] Derivative [Table] Net Amount Derivative Liability, Fair Value, Amount Offset Against Collateral Revenues: Revenues [Abstract] Document Period End Date Document Period End Date Non-cash interest expense Noncash Interest Expense Noncash Interest Expense Issuance of ordinary shares in conjunction with vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Acquisition of intangible assets Payments to Acquire Intangible Assets Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Deferred charge for income taxes on intercompany profit Deferred Tax, Intercompany Profit, Current Deferred Tax, Intercompany Profit, Current GW Pharmaceuticals plc GW Pharmaceuticals plc [Member] GW Pharmaceuticals plc Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Term Debt Instrument, Term Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Table] Term Loan Term Loan [Member] Term Loan [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Other non-current liabilities Other Liabilities, Noncurrent Manufacturing contracts Manufacturing Contracts [Member] Manufacturing Contracts [Member] Pro Forma Pro Forma [Member] Upfront Payments Upfront Payments [Member] Upfront Payments [Member] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Fair Value, Gross Liability Rylaze Rylaze [Member] Rylaze Schedule of Long-term Debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Estimated Future Amortization Costs Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Earnings Per Share [Abstract] Earnings Per Share [Abstract] Derivative asset Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet Derivative Asset Loss reclassified from accumulated other comprehensive income (loss) to foreign exchange gain (loss), net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Total Revenues Revenue from Contract with Customer Benchmark [Member] Vyxeos Vyxeos [Member] Vyxeos [Member] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Fair Value, Gross Asset Trademarks Trademarks [Member] Long-term debt, less current portion Long-term debt, less current portion Total long-term debt Long-term Debt, Excluding Current Maturities Liabilities: Liabilities, Fair Value Disclosure [Abstract] Capital redemption reserve Capital Redemption Reserve Capital redemption reserve created under Irish company law to preserve permanent capital in the company. Total share-based compensation expense, pre-tax Share-based Payment Arrangement, Expense Exchangeable Senior Notes Convertible Debt Securities [Member] Europe Europe [Member] Entity Current Reporting Status Entity Current Reporting Status Net income per ordinary share: Earnings Per Share, Basic and Diluted [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs Counterparty Name [Axis] Counterparty Name [Axis] Construction-in-progress Construction in Progress [Member] Cash and cash equivalents, at beginning of period Cash and cash equivalents, at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Number of preclinical compounds development and commercialization rights acquired. Number Of Preclinical Compounds Development And Commercialization Rights Acquired. Number Of Preclinical Compounds Development And Commercialization Rights Acquired. United States UNITED STATES Range of risk-free rates, maximum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Income taxes payable Taxes Payable, Current Current assets: Assets, Current [Abstract] Gross Carrying Amount Milestone payments Finite-Lived Intangible Assets, Gross Interest expense, net Interest Income (Expense), Nonoperating, Net Liability derivatives Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Issuance of ordinary shares in conjunction with exercise of share options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Weighted-average ordinary shares used in per share calculations - diluted (in shares) Weighted-average ordinary shares used in per share calculation - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Recurring Fair Value, Recurring [Member] Income Taxes Income Tax Disclosure [Text Block] Accrued interest Interest Payable, Current Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Country Region Country Region Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Loss recognized in foreign exchange gain (loss) Gain (Loss) on Fair Value Hedges Recognized in Earnings Schedule of Disposal Groups Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Denominator: Denominator [Abstract] Denominator [Abstract] Net Unrealized Loss From Hedging Activities Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Schedule of Weighted-Average Ordinary Shares Excluded from Computation of Diluted Net Income per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Credit Facility [Axis] Credit Facility [Axis] Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Entity Address, Address Line One Entity Address, Address Line One Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Entity Address, Address Line Two Entity Address, Address Line Two Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Basis of Presentation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Noncancelable purchase commitments due within one year Purchase Commitment, Remaining Minimum Amount Committed Weighted-average expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Payment of employee withholding taxes related to share-based awards Payment, Tax Withholding, Share-based Payment Arrangement Royalties and contract revenues Royalties and contract revenues Product And Services, Royalties And Contract Revenue [Member] Product And Services, Royalties And Contract Revenue [Member] Number of license, development and commercialization agreements Licensing Agreement, Number Of Agreements Licensing Agreement, Number Of Agreements Werewolf Werewolf [Member] Werewolf Foreign Exchange Forward Foreign Exchange Forward [Member] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Foreign exchange Goodwill, Foreign Currency Translation Gain (Loss) Money market funds Money Market Funds [Member] Loss Contingencies [Table] Loss Contingencies [Table] Ownership [Domain] Ownership [Domain] Jazz Securities Designated Activity Company Jazz Securities Designated Activity Company [Member] Jazz Securities Designated Activity Company Avadel Pharmaceuticals plc Lawsuit Avadel Pharmaceuticals plc Lawsuit [Member] Avadel Pharmaceuticals plc Lawsuit Current Fiscal Year End Date Current Fiscal Year End Date Derivative Financial Instruments Derivative, Collateral, Obligation to Return Securities McKesson McKesson Corporation [Member] McKesson Corporation [Member] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Statement [Table] Statement [Table] Other current assets Other current assets Other Assets, Current Adoption of New Accounting Standards and Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Operating lease liabilities, less current portion Increase (Decrease) In Operating Lease Liabilities, Noncurrent Increase (Decrease) In Operating Lease Liabilities, Noncurrent Unrecognized compensation cost related to unvested stock option, RSUs, and PRSUs Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Statistical Measurement [Axis] Statistical Measurement [Axis] Class action lawsuits filed Loss Contingency, New Claims Filed, Number Schedule of Offsetting Liabilities Offsetting Liabilities [Table Text Block] Gross Amounts of Recognized Assets/ Liabilities Derivative Liability, Fair Value, Gross Liability Subsequent Event Subsequent Event [Member] Derivative liabilities Derivative Liability [Abstract] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Total Finite-Lived Intangible Assets, Net Goodwill Goodwill, beginning of period Goodwill, end of period Goodwill Cost of product sales Cost of Sales [Member] Accounting Standards Update 2020-06 Accounting Standards Update 2020-06 [Member] Schedule of Gross Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Scenario [Domain] Scenario [Domain] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Acquired developed technologies Developed Technology Rights [Member] Schedule of the Fair Value of Outstanding Derivatives Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Computer equipment Computer Equipment [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Unamortized discount - equity component Debt Instrument, Unamortized Discount Inventory [Line Items] Inventory [Line Items] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Debt Long-term Debt [Text Block] Deferred tax benefit Deferred Income Tax Expense (Benefit) GW Litigation GW Litigation [Member] GW Litigation Accrued construction-in-progress Accrued Construction-In-Progress Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction-in-progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).